학술논문
Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting
Document Type
Article
Author
Source
In Blood Advances 8 August 2023 7(15):4089-4101
Subject
Language
ISSN
2473-9529